From the tDepartment of Pathology, Outram Road, Singapore, and *Middle Road Hospital, Singapore SUMMARY Two hundred and thirty-nine penicillinase-positive and 240 penicillinase-negative strains of Neisseria gonorrhoeae were tested for their susceptibility to cefotaxime. All were susceptible to cefotaxime at a concentration of 0'062 j.g/ml. Penicillinase-negative strains were less susceptible than penicillinase-positive strains. This is attributed to the use of prophylactic antibiotics by prostitutes, which has led to the selection of less susceptible penicillinase-negative strains but has not affected the susceptibility of penicillinase-positive strains. The minimum inhibitory concentrations of cefotaxime showed significant positive correlations with those of penicillin, ampicillin, tetracycline, and kanamycin but had a negative correlation with spectinomycin. The related cephalosporin, ceftizoxime, was found to be as effective as cefotaxime against penicillinase-positive and penicillinase-negative gonococci.
Introduction
Cefotaxime is a new cephalosporin that is highly effective against a wide range of bacteria' 2 and against penicillinase-positive (PPNG) and penicillinase-negative (non-PPNG) strains of Neisseria gonorrhoeae.3 4 Its level of activity against the gonococcus is several times greater than that of other cephalosporins (cefuroxime) and cephamycins (cefoxitin), which are currently used in the treatment of gonorrhoea caused by PPNG. In view of its potential value as a second-line antibiotic we have recently started monitoring the activity of this drug against routine isolates of gonococci. This paper reports its activity against 479 strains of gonococci and discusses the variation in the susceptibility of the gonococci isolated from different sources.
Ceftizoxime is another cephalosporin which has been recently introduced. It The least susceptible strains were the non-PPNG isolated from women, 23 -7%o of which had MICs of >0 016 ,g/ml. The most susceptible strains were PPNG from men and women, of which 6-5%o and 4 1%o respectively had MICs of >0 016 ,ug/ml. The MIC distribution of non-PPNG from women is significantly different from those of PPNG isolated from either men or women (table II) .
In contrast to isolates from women, only 9 9% of non-PPNG from men had MICs of .0-016 *g/ml, and the MIC distribution of these strains did not differ significantly from those of non-PPNG from women or PPNG from men and women (table II) .
MICs of cefotaxime showed strong positive correlation with those of penicillin. Both antibiotics showed significant positive correlations with ampicillin, tetracycline, and kanamycin, but had negative correlations with spectinomycin (table III) .
To determine if the MICs of penicillin for non-PPNG strains from men and women were different, (0 0005   28  42  70  26  37  63  133  0 001  14  20  34  10  34  44  78  0 002  11  23  34  14  25  39  73  0004   25  32  57  7  25  32  89  0 008  9  23  32  7  8  15  47  0-016  5  4  9  4  25  29  38  0 031  1  1  2  3  13  16  18  0-062  1  1  2  2  3  Total  93  146  239  71  169  240  479 E H Sng, V S Rajan, Roger Pang, and K L Yeo Seventy-two strains were also tested for their susceptibility to ceftizoxime. All the strains were susceptible to 0 008 Mg/ml (table V) .
Discussion
These findings confirm previous studies3 4 that cefotaxime is highly effective against PPNG and non-PPNG strains. All the strains tested were susceptible to a concentration of 0 062 Hg/ml.
The MICs for non-PPNG are significantly higher than those for PPNG strains. This differs from our previous study,3 in which it was found that PPNG strains were less susceptible to cefotaxime than non-PPNG. This is probably due to the difference in the types of patients from whom the gonococci were isolated. Non-PPNG from women had higher MICs than non-PPNG from men or PPNG from men or women, and non-PPNG from women had higher MICs of penicillin than similar strains from men. Since there was a significant positive correlation between MICs of cefotaxime and penicillin, any factor which produces a higher MIC of penicillin for strains from women is also likely to have contributed to a higher MIC of cefotaxime for such strains.
Almost all the specimens from women in the present study came from prostitutes, but only about 10% of those from men were from male prostitutes. A study presently being conducted shows that over 20% of male and female prostitutes are receiving prophylactic antibiotics at any one time. It is likely that the use of prophylactic antibiotics had resulted in a selection of strains which were less susceptible to penicillin among the prostitutes. Since almost all the women were prostitutes compared with only 10'%1 of the men, it is not surprising that the MIC of penicillin for non-PPNG strains from women were higher than those from men. Because of the positive correlation between MICs of penicillin and cefotaxime, the latter for non-PPNG strains from women were also higher than those from men.
The use of prophylactic antibiotics has apparently not resulted in any selective pressure in the case of PPNG. Hence no difference is observed in the MIC distributions of PPNG from men and women. Such strains were much more susceptible than non-PPNG from women. As only 10% of men were prostitutes, the MICs of non-PPNG from men were only slightly higher than the PPNG from men and women.
This study shows that the taking of prophylactic antibiotics may be an important factor in causing differences in the antibiotic susceptibility of gonococci from different populations. The antibiotic taken need not necessarily be the same as the one being tested, provided the two drugs show a strong positive correlation.
The correlation of cefotaxime to other antibiotics is very similar to that of penicillin. Both showed significant positive correlation to ampicillin, tetracycline, and kanamycin and a negative correlation to spectinomycin. This suggests that cefotaxime may be a suitable alternative to spectinomycin or vice versa in the event of treatment failure with either drug.
Ceftizoxime has a chemical structure very similar to that of cefotaxime5 and a similar range of antibacterial activity. This study shows that it is at least as effective against PPNG and non-PPNG strains as cefotaxime. Like cefotaxime it is also stable to hydrolysis by a variety of 13-lactamases. 7 Cefotaxime, in a dose of 500 mg, has been used successfully in the treatment of gonorrhoea.8 Thus, it is likely that ceftizoxime will also prove to be a potent drug in the treatment of gonorrhoea. 
